David Protein and 26North have secured new office spaces in Manhattan, signaling a continued expansion of their operations in the city’s competitive real‑estate market. The move reflects the companies’ growth strategies, with 26North—known for its data‑driven marketing solutions—looking to strengthen its client footprint in the financial district. Meanwhile, David Protein, a biotech firm focused on protein‑based therapeutics, is positioning itself to tap into the region’s vibrant life‑science ecosystem. Both leases underscore a broader trend of tech and biotech firms investing in high‑profile New York locations to attract top talent and foster collaboration.
26North, David Protein sign new Manhattan office leases The Business Journals
